Immunome ($IMNM) Insider Trading & Smart Money Activity
Immunome, Inc. ($IMNM) has 3 insider trades and 2 analyst ratings on file. Insiders filed 3 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
IMNM insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IMNM insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Robert LechleiderChief Medical Officer | Sell (Option exercise) | 55K sh | +21.7% | +16.4% | Read | |||||
| Insider | Robert LechleiderChief Medical Officer | Buy (Option exercise) | 55K sh | $480.15K | +21.7% | +16.4% | Read | ||||
| Insider | Max RosettChief Financial Officer | Sell (Option exercise) | 60K sh | +6.1% | +26.8% | Read | |||||
| Analyst | Wedbush | Reiterates to buy | PT $31 | +4.4% | +24.0% | Read | |||||
| Analyst | Wedbush | Reiterates to buy | PT $31 | +4.4% | +24.0% | Read |
1W / 1M / 6M = how IMNM moved from the trade or filing date.
Insider trading in IMNM: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Robert Lechleider | Chief Medical Officer | 2 | — | Jun 25, 2026 | |
| Max Rosett | Chief Financial Officer | 1 | — | Jun 15, 2026 |
Analyst ratings on IMNM
Frequently asked questions
What is the latest insider trade in IMNM?
Robert Lechleider, Chief Medical Officer filed a sell (option exercise) of 55K sh on Jun 25, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.